A genetic instrument for Mendelian randomization of fibrinogen
- PMID: 22388766
- PMCID: PMC4181528
- DOI: 10.1007/s10654-012-9666-x
A genetic instrument for Mendelian randomization of fibrinogen
Abstract
Mendelian randomization studies on fibrinogen commonly use a single genetic variant as an instrument, but this may explain only a small proportion of the total phenotypic variance. We examined the contribution of multiple common single nucleotide polymorphisms (SNPs) and haplotypes in the entire fibrinogen gene cluster to plasma fibrinogen levels in two prospective cohorts, for use as instruments in future Mendelian randomization studies. Genotypes for 20 SNPs were determined in 2,778 middle-age (49-64 years) men from the Second-Northwick-Park-Heart Study (NPHS-II). These were replicated in 3,705 men from the Whitehall-II study (WH-II). Plasma fibrinogen levels were determined six times in NPHS-II and three times in WH-II. The minor alleles of four SNPs from the FGB gene, two from the FGA gene, and one from the FGG gene were associated with higher plasma fibrinogen levels. SNP rs1800790 (-455G>A) commonly used in Mendelian randomization studies was associated with R2=1.22% of the covariate adjusted residual variance in fibrinogen level. A variable selection procedure identified one additional SNP: rs2070011 (FGA) altogether explaining R2=1.45% of the residual variance in fibrinogen level. Using these SNPs no evidence for causality between the fibrinogen levels and coronary heart diseases was found in instrumental variables analysis. In the replication cohort, WH-II, the effects of the two SNPs on fibrinogen levels were consistent with the NPHS-II results. There is statistical evidence for several functional sites in the fibrinogen gene cluster that determine an individual's plasma fibrinogen levels. Thus, a combination of several SNPs will provide a stronger instrument for fibrinogen Mendelian randomization studies.
Figures


References
-
- Danesh J, Lewington S, Thompson SG, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005;294(14):1799–809. - PubMed
-
- Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet. 1987;1(8548):1452–5. - PubMed
-
- de Maat MP, Kastelein JJ, Jukema JW, et al. 455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group. Arterioscler Thromb Vasc Biol. 1998;18(2):265–71. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- PG2005/014/BHF_/British Heart Foundation/United Kingdom
- RG/08/008/25291/BHF_/British Heart Foundation/United Kingdom
- 33014/PHS HHS/United States
- R01 HL036310/HL/NHLBI NIH HHS/United States
- G19/35/MRC_/Medical Research Council/United Kingdom
- G0100222/MRC_/Medical Research Council/United Kingdom
- AG13196/AG/NIA NIH HHS/United States
- DH_/Department of Health/United Kingdom
- R37 AG013196/AG/NIA NIH HHS/United States
- HL36310/HL/NHLBI NIH HHS/United States
- RG/08/008/BHF_/British Heart Foundation/United Kingdom
- HL036310/HL/NHLBI NIH HHS/United States
- R01 AG013196/AG/NIA NIH HHS/United States
- HS06516/HS/AHRQ HHS/United States
- PG/07/133/24260/BHF_/British Heart Foundation/United Kingdom
- RG/07/008/23674/BHF_/British Heart Foundation/United Kingdom
- G8802774/MRC_/Medical Research Council/United Kingdom
- G0902037/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Miscellaneous